Leqembi Iqlik subcutaneous injection now available in US
PositiveFinancial Markets

The recent approval of the Leqembi subcutaneous injection in the US marks a significant advancement in healthcare, particularly for patients requiring innovative treatment options. This new delivery method promises to enhance patient convenience and adherence to therapy, potentially improving health outcomes. As healthcare continues to evolve, such developments are crucial in providing effective solutions for chronic conditions.
— Curated by the World Pulse Now AI Editorial System